DIMETPRAMID (Dimethpramidum). 5-Nitro-4- dimetilamino-2- metoksi-N- (2 - ethyl ethoxylate) - benzamida hydrochloride.

     The structure and mechanism of action similar to sulpiridu (see), and metoclopramide.

     Has protivorvotnoe effect and applies to prevent palpitations and nausea and vomiting in the aftercare period, with radiation treatment and chemotherapy for cancer patients and others.

     Assign inside (to food) to 0.02 g 2 - 3 times daily; Intramuscularly for 1 ml 2% solution of 2 - 3 times daily.

     Higher doses : when administered 0.1 g / day, with 5 ml intramuscular a 2% solution (ie 0.1 grams) per day.

     Method of production : tablets of 0.02 g (20 mg); 2% solution in ampoules and 1 ml (20 mg).

     Storage : List B. In the dark place at a temperature no higher than 20 + C.

     Combined with sidnokarbom (see) issued in the form of tablets, coated with yellow skin, entitled <> (Dimetkarb Dimetcarbum). Protivorvotnogo applied as a means for one pill 3 - 4 times a day.

     Storage : List B.

     In combination with caffeine and ephedrine dimetpramid produced in aqueous solution (bright orange), entitled "Diksafen (Dixaphenum).

     Enter intramuscularly. Has protivorvotnoe effect and stimulates the cardiovascular system.

Materials allowed to copy only with the active hyperlink to the handbook of medicines